Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue

Below are the diagnostic substances stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX ) is $1.34 billion. IDEXX's PEG ratio is 2.10. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG ) is $216.35 million. Neogen's ROE for the same period is 11.22%. The trailing-twelve-month